2024-02-08 12:13:07 ET
Molina Healthcare, Inc. (MOH)
Q4 2023 Earnings Call Transcript
February 08, 2024, 08:00 AM ET
Company Participants
Jeff Geyer - VP of IR
Joe Zubretsky - President and CEO
Mark Keim - CFO
Conference Call Participants
A.J. Rice - UBS
Cal Sternick - JPMorgan
Kevin Fischbeck - Bank of America
Josh Raskin - Nephron
Justin Lake - Wolfe Research
Stephen Baxter - Wells Fargo
Nathan Rich - Goldman Sachs
Sarah James - Cantor Fitzgerald
George Hill - Deutsche Bank
Scott Fidel - Stephens
Presentation
Operator
Good morning, and welcome to the Molina Healthcare Fourth Quarter 2023 Earnings Call. All participants will be in a listen-only mode. [Operator Instructions] After today’s presentation there will be an opportunity to ask questions. [Operator Instructions] Please note, this event is being recorded. Standing in for Joe Krocheski today is Jeff Geyer, Vice President of Investor Relations. Please go ahead.
Jeff Geyer
Good morning, and welcome to Molina Healthcare's fourth quarter and full year 2023 earnings call. Joining me today are Molina's President and CEO, Joe Zubretsky, and our CFO, Mark Keim. A press release announcing our fourth quarter and full year 2023 earnings was distributed after the market closed yesterday and is available on our Investor Relations website. Shortly after the conclusion of this call, a replay will be available for 30 days. The numbers to access the replay are in the earnings release. For those of you who listen to the rebroadcast of this presentation, we remind you that all of the remarks made are as of today, Thursday, February 8, 2024, and have not been updated subsequent to the initial earnings call.
On this call, we will refer to certain non-GAAP measures. A reconciliation of these measures with the most directly comparable GAAP measures for 2023 and 2024 can be found in our fourth quarter 2023 earnings release. During the call, we will be making certain forward-looking statements, including, but not limited to, statements regarding our 2024 guidance, Medicaid redeterminations, our recent RFP awards and related revenue growth, our recent acquisition and M&A activity, our long-term growth strategy and our embedded earnings power and projected 2025 earnings per share.
Listeners are cautioned that all of our forward-looking statements are subject to certain risks and uncertainties that could cause our actual results to differ materially from our current expectations. We advise listeners to review the risk factors discussed in our Form 10-K annual report filed with the SEC as well as our risk factors listed in our Form 10-Q and Form 8-K filings with the SEC. After completion of our prepared remarks, we will open the call to take your questions.
I will now turn the call over to our Chief Executive Officer, Joe Zubretsky. Joe?...
Read the full article on Seeking Alpha
For further details see:
Molina Healthcare, Inc. (MOH) Q4 2023 Earnings Call Transcript